Stephan Toutain

Stephan Toutain is an experienced executive in the biotechnology sector, currently serving as Chief Operating Officer at PDS Biotechnology and Anavex Life Sciences. Previously, Stephan held the position of Chief Commercial Officer at Interleukin Genetics and served as a Member of the Board of Directors for Targeted Cancer Therapeutics. Additionally, Stephan has worked as an Executive Consultant in the biotech field. Educational background includes studies at the University of North Carolina at Chapel Hill - Kenan-Flagler Business School and the Business Institute of Lyon.